CSafe Appoints Will Romanowicz as Chief Legal Officer
Romanowicz brings more than a decade of legal, governance, and commercial leadership across regulated industries
Will brings extensive leadership experience across FDA and other regulated industries, spanning large global public companies and late-stage startups, with deep experience across diverse sectors including biotech, agribusiness, SaaS, food & beverage, and supplements.
Will most recently served in a dual legal and commercial role, where he led a cross-functional team responsible for legal affairs, government affairs, and external communications. Earlier in his career, Will practiced corporate law, advising companies on governance, restructuring, and complex transactional matters.
In his new role, he will lead CSafe's global legal function, overseeing corporate governance, regulatory compliance, and risk management as the Company continues to scale. Based at CSafe's
"Will's depth of legal and commercial experience across highly regulated industries makes him an excellent addition to our leadership team," said
About CSafe
CSafe is a global provider of temperature-controlled shipping solutions for the pharmaceutical and life sciences industry. The company offers active and passive cold chain products for bulk air cargo, parcel, and cell and gene therapy applications, serving pharmaceutical manufacturers, freight forwarders, and airlines worldwide. Founded in 1979 and headquartered in Monroe, Ohio, CSafe operates 75+ service locations worldwide and has safely delivered more than 10 billion doses in its products, ensuring life-enhancing therapies reach patients around the globe.
Email: [email protected]
Web: csafeglobal.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/csafe-appoints-will-romanowicz-as-chief-legal-officer-302871056.html
SOURCE CSafe
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- LV Petroleum Strengthens National Footprint with Two Travel Center Acquisitions and Food Expansion
- Anatool Launches to Improve Recognition and Treatment of Anaphylaxis
- Marvel Biosciences Announces Extension to Closing Date of Private Placement
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
FDASign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share